GlassScriptPhysician profile
Jerome K Steck
NPI 1972540367
$64,169.68
in general payments reported to CMS, 2019-2025
13 companies · $16K in 2025
The $16K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $9,250 · 2022: $99.73 · 2023: $1,203 · 2024: $13K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $1,742 · Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,006.92 |
| Travel and Lodging | $1,741.86 |
| Food and Beverage | $311.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $19,107.56 | 2023-2025 | N/A |
| Zimmer Biomet Holdings, INC. | $17,290.35 | 2019 | |
| Stryker Corporation | $16,693.78 | 2019-2020 | |
| Trilliant Surgical LLC. | $8,154.17 | 2025 | |
| Synthes USA Products LLC | $2,606.39 | 2024-2025 | |
| Depuy Synthes Sales INC. | $136.22 | 2023-2025 | Na, Motoband, Multiloc |
| Exactech, INC. | $99.73 | 2022 | |
| Djo, LLC | $22.86 | 2023 | Cmf |
| Merck Sharp & Dohme LLC | $21.67 | 2024 | Bridion |
| Integra Lifesciences Corporation | $13.62 | 2019 | |
| Tactile Systems Technology INC | $11.67 | 2019 | |
| Kerecis Limited | $6.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orthofix Medical, INC. | $5.00 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Steck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.